Night Vision System (NVS) and Driver Monitoring System (DMS)
Night Vision System (NVS) and Driver Monitoring System (DMS) market is segmented by Type and by A ... Read More
Global NGS-based RNA-seq Market Insights and Forecast to 2031
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-seq Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 High-Throughput Sequencing
1.2.3 Third-Generation Sequencing Technology
1.3 Market by Application
1.3.1 Global NGS-based RNA-seq Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Government Agencies
1.3.5 Academic and Research Organizations
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global NGS-based RNA-seq Market Perspective (2017-2028)
2.2 NGS-based RNA-seq Growth Trends by Region
2.2.1 NGS-based RNA-seq Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 NGS-based RNA-seq Historic Market Size by Region (2017-2022)
2.2.3 NGS-based RNA-seq Forecasted Market Size by Region (2023-2028)
2.3 NGS-based RNA-seq Market Dynamics
2.3.1 NGS-based RNA-seq Industry Trends
2.3.2 NGS-based RNA-seq Market Drivers
2.3.3 NGS-based RNA-seq Market Challenges
2.3.4 NGS-based RNA-seq Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS-based RNA-seq Players by Revenue
3.1.1 Global Top NGS-based RNA-seq Players by Revenue (2017-2022)
3.1.2 Global NGS-based RNA-seq Revenue Market Share by Players (2017-2022)
3.2 Global NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NGS-based RNA-seq Revenue
3.4 Global NGS-based RNA-seq Market Concentration Ratio
3.4.1 Global NGS-based RNA-seq Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-seq Revenue in 2021
3.5 NGS-based RNA-seq Key Players Head office and Area Served
3.6 Key Players NGS-based RNA-seq Product Solution and Service
3.7 Date of Enter into NGS-based RNA-seq Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-seq Breakdown Data by Type
4.1 Global NGS-based RNA-seq Historic Market Size by Type (2017-2022)
4.2 Global NGS-based RNA-seq Forecasted Market Size by Type (2023-2028)
5 NGS-based RNA-seq Breakdown Data by Application
5.1 Global NGS-based RNA-seq Historic Market Size by Application (2017-2022)
5.2 Global NGS-based RNA-seq Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America NGS-based RNA-seq Market Size (2017-2028)
6.2 North America NGS-based RNA-seq Market Size by Type
6.2.1 North America NGS-based RNA-seq Market Size by Type (2017-2022)
6.2.2 North America NGS-based RNA-seq Market Size by Type (2023-2028)
6.2.3 North America NGS-based RNA-seq Market Share by Type (2017-2028)
6.3 North America NGS-based RNA-seq Market Size by Application
6.3.1 North America NGS-based RNA-seq Market Size by Application (2017-2022)
6.3.2 North America NGS-based RNA-seq Market Size by Application (2023-2028)
6.3.3 North America NGS-based RNA-seq Market Share by Application (2017-2028)
6.4 North America NGS-based RNA-seq Market Size by Country
6.4.1 North America NGS-based RNA-seq Market Size by Country (2017-2022)
6.4.2 North America NGS-based RNA-seq Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe NGS-based RNA-seq Market Size (2017-2028)
7.2 Europe NGS-based RNA-seq Market Size by Type
7.2.1 Europe NGS-based RNA-seq Market Size by Type (2017-2022)
7.2.2 Europe NGS-based RNA-seq Market Size by Type (2023-2028)
7.2.3 Europe NGS-based RNA-seq Market Share by Type (2017-2028)
7.3 Europe NGS-based RNA-seq Market Size by Application
7.3.1 Europe NGS-based RNA-seq Market Size by Application (2017-2022)
7.3.2 Europe NGS-based RNA-seq Market Size by Application (2023-2028)
7.3.3 Europe NGS-based RNA-seq Market Share by Application (2017-2028)
7.4 Europe NGS-based RNA-seq Market Size by Country
7.4.1 Europe NGS-based RNA-seq Market Size by Country (2017-2022)
7.4.2 Europe NGS-based RNA-seq Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-seq Market Size (2017-2028)
8.2 Asia-Pacific NGS-based RNA-seq Market Size by Type
8.2.1 Asia-Pacific NGS-based RNA-seq Market Size by Type (2017-2022)
8.2.2 Asia-Pacific NGS-based RNA-seq Market Size by Type (2023-2028)
8.2.3 Asia-Pacific NGS-based RNA-seq Market Share by Type (2017-2028)
8.3 Asia-Pacific NGS-based RNA-seq Market Size by Application
8.3.1 Asia-Pacific NGS-based RNA-seq Market Size by Application (2017-2022)
8.3.2 Asia-Pacific NGS-based RNA-seq Market Size by Application (2023-2028)
8.3.3 Asia-Pacific NGS-based RNA-seq Market Share by Application (2017-2028)
8.4 Asia-Pacific NGS-based RNA-seq Market Size by Region
8.4.1 Asia-Pacific NGS-based RNA-seq Market Size by Region (2017-2022)
8.4.2 Asia-Pacific NGS-based RNA-seq Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America NGS-based RNA-seq Market Size (2017-2028)
9.2 Latin America NGS-based RNA-seq Market Size by Type
9.2.1 Latin America NGS-based RNA-seq Market Size by Type (2017-2022)
9.2.2 Latin America NGS-based RNA-seq Market Size by Type (2023-2028)
9.2.3 Latin America NGS-based RNA-seq Market Share by Type (2017-2028)
9.3 Latin America NGS-based RNA-seq Market Size by Application
9.3.1 Latin America NGS-based RNA-seq Market Size by Application (2017-2022)
9.3.2 Latin America NGS-based RNA-seq Market Size by Application (2023-2028)
9.3.3 Latin America NGS-based RNA-seq Market Share by Application (2017-2028)
9.4 Latin America NGS-based RNA-seq Market Size by Country
9.4.1 Latin America NGS-based RNA-seq Market Size by Country (2017-2022)
9.4.2 Latin America NGS-based RNA-seq Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-seq Market Size (2017-2028)
10.2 Middle East & Africa NGS-based RNA-seq Market Size by Type
10.2.1 Middle East & Africa NGS-based RNA-seq Market Size by Type (2017-2022)
10.2.2 Middle East & Africa NGS-based RNA-seq Market Size by Type (2023-2028)
10.2.3 Middle East & Africa NGS-based RNA-seq Market Share by Type (2017-2028)
10.3 Middle East & Africa NGS-based RNA-seq Market Size by Application
10.3.1 Middle East & Africa NGS-based RNA-seq Market Size by Application (2017-2022)
10.3.2 Middle East & Africa NGS-based RNA-seq Market Size by Application (2023-2028)
10.3.3 Middle East & Africa NGS-based RNA-seq Market Share by Application (2017-2028)
10.4 Middle East & Africa NGS-based RNA-seq Market Size by Country
10.4.1 Middle East & Africa NGS-based RNA-seq Market Size by Country (2017-2022)
10.4.2 Middle East & Africa NGS-based RNA-seq Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-seq Introduction
11.1.4 Illumina Revenue in NGS-based RNA-seq Business (2017-2022)
11.1.5 Illumina Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific NGS-based RNA-seq Introduction
11.2.4 Thermo Fisher Scientific Revenue in NGS-based RNA-seq Business (2017-2022)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Pacific Biosciences Of California
11.3.1 Pacific Biosciences Of California Company Details
11.3.2 Pacific Biosciences Of California Business Overview
11.3.3 Pacific Biosciences Of California NGS-based RNA-seq Introduction
11.3.4 Pacific Biosciences Of California Revenue in NGS-based RNA-seq Business (2017-2022)
11.3.5 Pacific Biosciences Of California Recent Developments
11.4 Qaigen
11.4.1 Qaigen Company Details
11.4.2 Qaigen Business Overview
11.4.3 Qaigen NGS-based RNA-seq Introduction
11.4.4 Qaigen Revenue in NGS-based RNA-seq Business (2017-2022)
11.4.5 Qaigen Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Introduction
11.5.4 F. Hoffmann-La Roche Revenue in NGS-based RNA-seq Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Details
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies NGS-based RNA-seq Introduction
11.6.4 Agilent Technologies Revenue in NGS-based RNA-seq Business (2017-2022)
11.6.5 Agilent Technologies Recent Developments
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Details
11.7.2 Oxford Nanopore Technologies Business Overview
11.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Introduction
11.7.4 Oxford Nanopore Technologies Revenue in NGS-based RNA-seq Business (2017-2022)
11.7.5 Oxford Nanopore Technologies Recent Developments
11.8 Perkinelmer
11.8.1 Perkinelmer Company Details
11.8.2 Perkinelmer Business Overview
11.8.3 Perkinelmer NGS-based RNA-seq Introduction
11.8.4 Perkinelmer Revenue in NGS-based RNA-seq Business (2017-2022)
11.8.5 Perkinelmer Recent Developments
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Details
11.9.2 Eurofins Scientific Business Overview
11.9.3 Eurofins Scientific NGS-based RNA-seq Introduction
11.9.4 Eurofins Scientific Revenue in NGS-based RNA-seq Business (2017-2022)
11.9.5 Eurofins Scientific Recent Developments
11.10 Gatc Biotech
11.10.1 Gatc Biotech Company Details
11.10.2 Gatc Biotech Business Overview
11.10.3 Gatc Biotech NGS-based RNA-seq Introduction
11.10.4 Gatc Biotech Revenue in NGS-based RNA-seq Business (2017-2022)
11.10.5 Gatc Biotech Recent Developments
11.11 Macrogen
11.11.1 Macrogen Company Details
11.11.2 Macrogen Business Overview
11.11.3 Macrogen NGS-based RNA-seq Introduction
11.11.4 Macrogen Revenue in NGS-based RNA-seq Business (2017-2022)
11.11.5 Macrogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global NGS-based RNA-seq Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of High-Throughput Sequencing
Table 3. Key Players of Third-Generation Sequencing Technology
Table 4. Global NGS-based RNA-seq Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global NGS-based RNA-seq Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global NGS-based RNA-seq Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global NGS-based RNA-seq Market Share by Region (2017-2022)
Table 8. Global NGS-based RNA-seq Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global NGS-based RNA-seq Market Share by Region (2023-2028)
Table 10. NGS-based RNA-seq Market Trends
Table 11. NGS-based RNA-seq Market Drivers
Table 12. NGS-based RNA-seq Market Challenges
Table 13. NGS-based RNA-seq Market Restraints
Table 14. Global NGS-based RNA-seq Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global NGS-based RNA-seq Revenue Share by Players (2017-2022)
Table 16. Global Top NGS-based RNA-seq by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2021)
Table 17. Ranking of Global Top NGS-based RNA-seq Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by NGS-based RNA-seq Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players NGS-based RNA-seq Product Solution and Service
Table 21. Date of Enter into NGS-based RNA-seq Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NGS-based RNA-seq Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global NGS-based RNA-seq Revenue Market Share by Type (2017-2022)
Table 25. Global NGS-based RNA-seq Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global NGS-based RNA-seq Revenue Market Share by Type (2023-2028)
Table 27. Global NGS-based RNA-seq Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global NGS-based RNA-seq Revenue Share by Application (2017-2022)
Table 29. Global NGS-based RNA-seq Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global NGS-based RNA-seq Revenue Share by Application (2023-2028)
Table 31. North America NGS-based RNA-seq Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America NGS-based RNA-seq Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America NGS-based RNA-seq Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America NGS-based RNA-seq Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America NGS-based RNA-seq Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America NGS-based RNA-seq Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe NGS-based RNA-seq Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe NGS-based RNA-seq Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe NGS-based RNA-seq Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe NGS-based RNA-seq Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe NGS-based RNA-seq Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe NGS-based RNA-seq Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific NGS-based RNA-seq Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific NGS-based RNA-seq Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific NGS-based RNA-seq Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific NGS-based RNA-seq Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific NGS-based RNA-seq Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific NGS-based RNA-seq Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America NGS-based RNA-seq Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America NGS-based RNA-seq Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America NGS-based RNA-seq Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America NGS-based RNA-seq Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America NGS-based RNA-seq Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America NGS-based RNA-seq Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa NGS-based RNA-seq Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa NGS-based RNA-seq Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa NGS-based RNA-seq Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa NGS-based RNA-seq Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa NGS-based RNA-seq Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa NGS-based RNA-seq Market Size by Country (2023-2028) & (US$ Million)
Table 61. Illumina Company Details
Table 62. Illumina Business Overview
Table 63. Illumina NGS-based RNA-seq Product
Table 64. Illumina Revenue in NGS-based RNA-seq Business (2017-2022) & (US$ Million)
Table 65. Illumina Recent Developments
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific NGS-based RNA-seq Product
Table 69. Thermo Fisher Scientific Revenue in NGS-based RNA-seq Business (2017-2022) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Developments
Table 71. Pacific Biosciences Of California Company Details
Table 72. Pacific Biosciences Of California Business Overview
Table 73. Pacific Biosciences Of California NGS-based RNA-seq Product
Table 74. Pacific Biosciences Of California Revenue in NGS-based RNA-seq Business (2017-2022) & (US$ Million)
Table 75. Pacific Biosciences Of California Recent Developments
Table 76. Qaigen Company Details
Table 77. Qaigen Business Overview
Table 78. Qaigen NGS-based RNA-seq Product
Table 79. Qaigen Revenue in NGS-based RNA-seq Business (2017-2022) & (US$ Million)
Table 80. Qaigen Recent Developments
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche NGS-based RNA-seq Product
Table 84. F. Hoffmann-La Roche Revenue in NGS-based RNA-seq Business (2017-2022) & (US$ Million)
Table 85. F. Hoffmann-La Roche Recent Developments
Table 86. Agilent Technologies Company Details
Table 87. Agilent Technologies Business Overview
Table 88. Agilent Technologies NGS-based RNA-seq Product
Table 89. Agilent Technologies Revenue in NGS-based RNA-seq Business (2017-2022) & (US$ Million)
Table 90. Agilent Technologies Recent Developments
Table 91. Oxford Nanopore Technologies Company Details
Table 92. Oxford Nanopore Technologies Business Overview
Table 93. Oxford Nanopore Technologies NGS-based RNA-seq Product
Table 94. Oxford Nanopore Technologies Revenue in NGS-based RNA-seq Business (2017-2022) & (US$ Million)
Table 95. Oxford Nanopore Technologies Recent Developments
Table 96. Perkinelmer Company Details
Table 97. Perkinelmer Business Overview
Table 98. Perkinelmer NGS-based RNA-seq Product
Table 99. Perkinelmer Revenue in NGS-based RNA-seq Business (2017-2022) & (US$ Million)
Table 100. Perkinelmer Recent Developments
Table 101. Eurofins Scientific Company Details
Table 102. Eurofins Scientific Business Overview
Table 103. Eurofins Scientific NGS-based RNA-seq Product
Table 104. Eurofins Scientific Revenue in NGS-based RNA-seq Business (2017-2022) & (US$ Million)
Table 105. Eurofins Scientific Recent Developments
Table 106. Gatc Biotech Company Details
Table 107. Gatc Biotech Business Overview
Table 108. Gatc Biotech NGS-based RNA-seq Product
Table 109. Gatc Biotech Revenue in NGS-based RNA-seq Business (2017-2022) & (US$ Million)
Table 110. Gatc Biotech Recent Developments
Table 111. Macrogen Company Details
Table 112. Macrogen Business Overview
Table 113. Macrogen NGS-based RNA-seq Product
Table 114. Macrogen Revenue in NGS-based RNA-seq Business (2017-2022) & (US$ Million)
Table 115. Macrogen Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NGS-based RNA-seq Market Share by Type: 2021 VS 2028
Figure 2. High-Throughput Sequencing Features
Figure 3. Third-Generation Sequencing Technology Features
Figure 4. Global NGS-based RNA-seq Market Share by Application: 2021 VS 2028
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Biopharma Companies Case Studies
Figure 7. Government Agencies Case Studies
Figure 8. Academic and Research Organizations Case Studies
Figure 9. Other Case Studies
Figure 10. NGS-based RNA-seq Report Years Considered
Figure 11. Global NGS-based RNA-seq Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global NGS-based RNA-seq Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global NGS-based RNA-seq Market Share by Region: 2021 VS 2028
Figure 14. Global NGS-based RNA-seq Market Share by Players in 2021
Figure 15. Global Top NGS-based RNA-seq Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-seq as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by NGS-based RNA-seq Revenue in 2021
Figure 17. North America NGS-based RNA-seq Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America NGS-based RNA-seq Market Size Market Share by Type (2017-2028)
Figure 19. North America NGS-based RNA-seq Market Size Market Share by Application (2017-2028)
Figure 20. North America NGS-based RNA-seq Market Size Share by Country (2017-2028)
Figure 21. United States NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe NGS-based RNA-seq Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe NGS-based RNA-seq Market Size Market Share by Type (2017-2028)
Figure 25. Europe NGS-based RNA-seq Market Size Market Share by Application (2017-2028)
Figure 26. Europe NGS-based RNA-seq Market Size Share by Country (2017-2028)
Figure 27. Germany NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific NGS-based RNA-seq Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific NGS-based RNA-seq Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific NGS-based RNA-seq Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific NGS-based RNA-seq Market Size Share by Region (2017-2028)
Figure 37. China NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America NGS-based RNA-seq Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America NGS-based RNA-seq Market Size Market Share by Type (2017-2028)
Figure 45. Latin America NGS-based RNA-seq Market Size Market Share by Application (2017-2028)
Figure 46. Latin America NGS-based RNA-seq Market Size Share by Country (2017-2028)
Figure 47. Mexico NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa NGS-based RNA-seq Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa NGS-based RNA-seq Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa NGS-based RNA-seq Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa NGS-based RNA-seq Market Size Share by Country (2017-2028)
Figure 53. Turkey NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE NGS-based RNA-seq Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Illumina Revenue Growth Rate in NGS-based RNA-seq Business (2017-2022)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in NGS-based RNA-seq Business (2017-2022)
Figure 58. Pacific Biosciences Of California Revenue Growth Rate in NGS-based RNA-seq Business (2017-2022)
Figure 59. Qaigen Revenue Growth Rate in NGS-based RNA-seq Business (2017-2022)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in NGS-based RNA-seq Business (2017-2022)
Figure 61. Agilent Technologies Revenue Growth Rate in NGS-based RNA-seq Business (2017-2022)
Figure 62. Oxford Nanopore Technologies Revenue Growth Rate in NGS-based RNA-seq Business (2017-2022)
Figure 63. Perkinelmer Revenue Growth Rate in NGS-based RNA-seq Business (2017-2022)
Figure 64. Eurofins Scientific Revenue Growth Rate in NGS-based RNA-seq Business (2017-2022)
Figure 65. Gatc Biotech Revenue Growth Rate in NGS-based RNA-seq Business (2017-2022)
Figure 66. Macrogen Revenue Growth Rate in NGS-based RNA-seq Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Illumina Thermo Fisher Scientific Pacific Biosciences Of California Qaigen F. Hoffmann-La Roche Agilent Technologies Oxford Nanopore Technologies Perkinelmer Eurofins Scientific Gatc Biotech Macrogen